An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)

Update Il y a 4 ans
Reference: NCT01689025

Woman and Man

Extract

This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to investigate the safety and tolerability of NNC0114-0006 in subjects with systemic lupus erythematosus (SLE) concomitantly treated with stable background therapies.


Inclusion criteria

  • Inflammation ,Systemic Lupus Erythematosus


Links